Skip to content
Home/Companies/Biotech/Pepkon

Pepkon

Biotech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Pepkon?

Pepkon is a French Biotech company, currently owned by Aloe Private Equity since 2019.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Aloe Private Equity
Investor
Aloe Private Equity
Aloe Environment Fund III · 2014 · Growth

Key facts

HQFrance
SectorBiotech

More from Aloe Environment Fund III

Other portfolio companies in the same fund.

DeepLife
Active
BiotechFrance· 2024
WhiteLab Genomics
WhiteLab Genomics
Active
BiotechFrance· 2020

More Aloe Private Equity portfolio companies

From the same investor, across funds.

DiogenX
Active
BiotechFrance
O-Kidia
Active
Austral DX
Austral DX
Active
MedTechFrance· 2025
EVerZom
Active
BiotechFrance· 2025
Biomemory
Active
TMTFrance· 2024
Polygon
Active
BiotechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Pepkon?

Pepkon is currently owned by Aloe Private Equity, through Aloe Environment Fund III, since 2019.

When did Aloe Private Equity acquire Pepkon?

Aloe Private Equity acquired Pepkon in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue